Philip Jochelson
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Philip Jochelson
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.
14
| Extinct | Pharmaceuticals: Major | 14 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Philip Jochelson tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Director/Board Member | |
Cardiac Dimensions, Inc.
 Cardiac Dimensions, Inc. Medical SpecialtiesHealth Technology Cardiac Dimensions, Inc. develops novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. It offers the CARILLON Mitral Contour System, a proprietary and implantable device designed to be positioned in the coronary sinus vein using cardiac catheterization techniques. The firm also offers patient enrollment, clinical testing, and medical consulting services. The company was founded by James W. Fitzsimmons and Scott Jordan Wolf in 2001 and is headquartered in Kirkland, WA. | Medical Specialties | Director/Board Member | |
SkinMedica, Inc.
 SkinMedica, Inc. Medical DistributorsDistribution Services SkinMedica, Inc. is a specialty skin care pharmaceutical company. It develops, acquires, and commercializes products for treatment of dermatologic conditions and improvement of skin appearance. It markets and sells to physicians, with a focus on aesthetics, both prescriptions and non-prescription skin care products. SkinMedica was founded in May 1999. Its company headquarters are located in Carlsbad, California. Company already EXT. Filed in HOL tracker. | Medical Distributors | Director/Board Member Founder | |
PowerVision, Inc.
 PowerVision, Inc. Electronic ComponentsElectronic Technology PowerVision, Inc. develops fluid-controlled intraocular lens. The firm provides FluidVision accommodating intraocular lens technology, which restores the vision of youth to middle aged or elderly individuals affected by presbyopia and cataracts regain to adjust focus for clear vision at all distances. The company was founded by Matthew A. Frinzi, Randy McDonald, and Barry Cheskin in 2002 and is headquartered in Belmont, CA. | Electronic Components | Director/Board Member | |
NovaCardia, Inc.
 NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Founder | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ZOGENIX, INC. | Pharmaceuticals: Major | Founder Director/Board Member Founder Director/Board Member Director/Board Member | |
| EVOKE PHARMA, INC. | Pharmaceuticals: Major | Founder Founder | |
Peplin, Inc.
 Peplin, Inc. Pharmaceuticals: MajorHealth Technology Peplin, Inc. develops drugs and pharmaceutical products. The company was founded by James Harrison Aylward in 1998 and is headquartered in Emeryville, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| SCORPIUS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Kalyra Pharmaceuticals, Inc.
 Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kalyra Pharmaceuticals, Inc. manufactures small molecule drugs. The company was founded by Brian T. Dorsey, Cam L. Garner and Kevin Bunker and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder Director/Board Member | |
Southern Methodist University
 Southern Methodist University Other Consumer ServicesConsumer Services Southern Methodist University is a private university near the center of Dallas, SMU offers undergraduate, graduate, and professional programs through seven schools in the humanities and sciences, business, the performing, visual, and communication arts, engineering, education and human development, law, and theology. | College/University | Masters Business Admin | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact LLC (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| University of Kansas | College/University | Undergraduate Degree | |
| CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Founder | |
Ares-Serono Group
 Ares-Serono Group Pharmaceuticals: MajorHealth Technology Ares-Serono Group is a Swiss pharmaceutical company that manufactures and wholesales pharmaceutical products. The private company is based in Geneva, Switzerland. and has subsidiaries in Ecuador. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Kansas University Endowment Association
 Kansas University Endowment Association Miscellaneous Commercial ServicesCommercial Services Kansas University Endowment Association operates fundraising foundation for the University of Kansas, KU Endowment partners with donors in providing philanthropic support to build a greater KU. The company was founded in 1891 and is headquartered in Lawrence, KS. | Miscellaneous Commercial Services | Director/Board Member | |
| The Hoover Institution | Director/Board Member | ||
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Chairman | |
SHVMS, LLC
 SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | Investment Managers | Private Equity Investor | |
Excaliard Pharmaceuticals, Inc.
 Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman | |
| Kansas Association of Defense Counsel | Director/Board Member | ||
SFJ Pharmaceuticals, Inc.
 SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology SFJ Pharmaceuticals, Inc. develops pharmaceuticals drugs. It offers drugs for cancer, kidney, thyroid, leukemia, and lung cancer. The company was founded by Roberto DeBenedetto in January 2009 and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| DERMIRA, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
ALASTIN Skincare, Inc.
 ALASTIN Skincare, Inc. Household/Personal CareConsumer Non-Durables Alastin Skincare, Inc. develops and markets skin care products that reinvigorate, protect, and maintain healthy skin. It offers skin procedures such as injectables, laser resurfacing, microneedling, peels, photo rejuvination, radio frequency, skin tightening, surgical procedures, and ultra sound therapy. The company was founded by Scott L. Glenn and Cam L. Garner in 2015 and is headquartered in Carlsbad, CA. | Household/Personal Care | Founder Founder | |
Oncternal Oncology, Inc.
 Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder Director/Board Member | |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
| JASPER THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 49 |
| Canada | 2 |
| Svizzera | 2 |
Settori
| Health Technology | 36 |
| Finance | 5 |
| Commercial Services | 4 |
| Distribution Services | 3 |
| Consumer Services | 3 |
Posizioni
| Director/Board Member | 146 |
| Chairman | 41 |
| Founder | 39 |
| Independent Dir/Board Member | 36 |
| Corporate Officer/Principal | 32 |
Contatti più connessi
| Insiders | |
|---|---|
| Kurt von Emster | 34 |
| Thomas Wiggans | 31 |
| Dan Turner | 29 |
| Cam Garner | 28 |
| Scott Glenn | 28 |
| Kurt Wheeler | 28 |
| Louis C. Bock | 27 |
| Richard Pascoe | 13 |
| Matthew Onaitis | 12 |
| Kenneth M. Cohen | 12 |
| Erle T. Mast | 11 |
| James J. L'Italien | 10 |
| Jill Howe | 10 |
| Robert Lewis Jones | 5 |
- Borsa valori
- Insiders
- Philip Jochelson
- Connessioni Società
